Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Epsilon Energy Ltd | Bryan H. Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 2,234,847 | 2,869,560 (10%) | 8% | - | Common Shares | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 2,075,000 | 2,075,000 | - | - | Stock Option (right to buy) | |
| Robinhood Markets Inc (Class A) | Meyer Rais Malka | Director | 21 Nov 2025 | 1,000,000 | 1,000,000 | - | - | Variable Share Forward Contract (obligation to sell) | ||
| AMKOR Tech Inc | James J. Kim | Ten Percent Owner, Member of 10% owner group (4) | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 965,000 | 965,000 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 925,000 | 925,000 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | Donald P. Monaco | Director | 21 Nov 2025 | 745,032 | 0 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| NextTrip Inc | Donald P. Monaco | Director | 21 Nov 2025 | 745,032 | 2,206,673 (152%) | 51% | 0 | Common Stock | ||
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 700,000 | 700,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 700,000 | 0 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | David Jiang | Director | 21 Nov 2025 | 659,316 | 1,561,958 (107%) | 45% | 0 | Common Stock | ||
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 625,000 | 625,000 | - | - | Stock Option (right to buy) | |
| Cerence Inc | Brian Matthew Krzanich | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 10.35 per share. | 21 Nov 2025 | 552,766 | 1,458,753 (4%) | 1% | 10.3 | 5,721,128 | Common Stock |
| Bitcoin Depot Inc (Class A) | Scott Buchanan | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 500,000 | 626,276 | - | 0 | Class A Common Stock | |
| American Integrity Insurance Grp Inc | Robert Ritchie | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 21 Nov 2025 | 475,000 | 2,454,500 | - | 19 | 9,025,000 | Common Stock |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 473,334 | 473,334 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 473,334 | 0 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | David Jiang | Director | 21 Nov 2025 | 427,528 | 0 | - | - | Series I Nonvoting Convertible Preferred Stock | ||
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 350,000 | 350,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 350,000 | 0 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | William Kerby | Director | 21 Nov 2025 | 331,124 | 1,586,117 (109%) | 22% | 0 | Common Stock | ||
| NextTrip Inc | William Kerby | Director | 21 Nov 2025 | 331,124 | 0 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| DBV Tech (ADR) | Kevin Michael Trapp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 316,250 | 316,250 | - | - | Employee Stock Option (right to buy) | |
| Mirion Tech Inc (Class A) | Lawrence D. Kingsley | Director | Sale of securities on an exchange or to another person at price $ 23.83 per share. | 21 Nov 2025 | 300,000 | 3,900,000 | - | 23.8 | 7,148,400 | Class A Common Stock |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 300,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Tyra Biosciences Inc | Robert J. More | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 21 Nov 2025 | 246,871 | 3,833,425 | - | 20.3 | 5,000,026 | Common Stock |
| Cerence Inc | Jennifer Salinas | EVP Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 10.35 per share. | 21 Nov 2025 | 242,044 | 588,333 (1%) | 0% | 10.3 | 2,505,155 | Common Stock |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 239,703 | 239,703 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 239,703 | 0 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | David Jiang | Director | 21 Nov 2025 | 231,788 | 0 | - | - | Series J Nonvoting Convertible Preferred Stock | ||
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 21 Nov 2025 | 192,870 | 216,706,448 (32%) | 0% | 1.3 | 257,481 | Common Stock |
| DBV Tech (ADR) | Virginie Boucinha | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 192,000 | 192,000 | - | - | Employee Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 21 Nov 2025 | 191,490 | 216,513,578 (32%) | 0% | 1.3 | 254,682 | Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,348,367 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,535,867 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,723,367 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,723,367 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,348,367 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 187,500 | 17,535,867 (25%) | 0% | 37.0 | 6,941,888 | Common Stock | |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 21 Nov 2025 | 187,200 | 1,037,533 | - | 1.1 | 198,432 | Class A Common Stock |
| SuRo Cap Corp | Mark D. Klein | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 174,465 | 1,705,055 (8%) | 0% | 0 | Common Stock | |
| American Integrity Insurance Grp Inc | Steven Smathers | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 21 Nov 2025 | 171,800 | 173,414 | - | 19 | 3,264,200 | Common Stock |
| fuboTV Inc | John Janedis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 21 Nov 2025 | 170,585 | 130,478 | - | 3.2 | 539,390 | Class A Common Stock |
| NextTrip Inc | John Patrick McMahon | Chief Operating Officer | 21 Nov 2025 | 168,414 | 0 | - | - | Series O Nonvoting Convertible Preferred Stock | ||
| NextTrip Inc | John Patrick McMahon | Chief Operating Officer | 21 Nov 2025 | 168,414 | 168,414 (11%) | 11% | 0 | Common Stock | ||
| Cerence Inc | Antonio Rodriquez | CFO | Grant, award, or other acquisition of securities at price $ 10.35 per share. | 21 Nov 2025 | 166,821 | 443,552 (1%) | 0% | 10.3 | 1,726,597 | Common Stock |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 155,090 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 155,090 | 155,090 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 149,970 | 1,702,583 | - | - | Class A Common Stock | |
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 149,970 | 449,910 | - | - | Restricted Stock Units | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 149,970 | 301,063 | - | - | Class A Common Stock | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 149,970 | 449,910 | - | - | Restricted Stock Units | |
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 21 Nov 2025 | 138,753 | 1,563,830 | - | 3.2 | 438,737 | Class A Common Stock |
| Priority Technology Holdings | Timothy M. O’Leary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 138,462 | 0 | - | - | Restricted Stock Unit | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 135,134 | 135,134 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 135,134 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 131,700 | 131,700 | - | - | Stock Option (right to buy) | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 21 Nov 2025 | 130,478 | 0 | - | 3.1 | 407,091 | Class A Common Stock |
| authID Inc | Stephen Jeffrey Garchik | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 21 Nov 2025 | 126,608 | 130,975 (0%) | 0% | 1.7 | 216,500 | Common Stock |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 117,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 117,000 | 117,000 | - | - | Stock Option (right to buy) | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 1,012,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 787,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 21 Nov 2025 | 112,500 | 900,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 787,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 900,000 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 1,012,500 (1%) | 0% | 37.0 | 4,165,133 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 21 Nov 2025 | 112,500 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 110,451 | 220,902 | - | - | Restricted Share Units | |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 110,451 | 237,452 (0%) | 0% | 0 | Common Shares | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 106,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 21 Nov 2025 | 102,371 | 216,228,819 (32%) | 0% | 1.3 | 133,082 | Common Stock |
| Mobix Labs Inc (Class A) | Philip Sansone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 21 Nov 2025 | 100,044 | 1,935,841 | - | 0.4 | 41,218 | Class A Common Stock |
| Fox Corp (Class A) | Keith Rupert Murdoch | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 59.26 per share. | 21 Nov 2025 | 100,000 | 1,100,862 (0%) | 0% | 59.3 | 5,926,000 | Class B Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.18 per share. | 21 Nov 2025 | 100,000 | 407,486 | - | 35.2 | 3,517,520 | Class A Ordinary Shares, par value $0.05 per share |
| SkyWater Tech Inc | Loren A. Unterseher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.53 per share. | 21 Nov 2025 | 100,000 | 6,711,256 | - | 14.5 | 1,452,670 | Common Stock |
| SkyWater Tech Inc | Loren A. Unterseher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.13 per share. | 21 Nov 2025 | 100,000 | 6,611,256 | - | 14.1 | 1,412,640 | Common Stock |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| SkyWater Tech Inc | Loren A. Unterseher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.13 per share. | 21 Nov 2025 | 100,000 | 4,687,394 | - | 14.1 | 1,412,640 | Common Stock |
| SkyWater Tech Inc | Loren A. Unterseher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.53 per share. | 21 Nov 2025 | 100,000 | 4,587,394 | - | 14.5 | 1,452,670 | Common Stock |
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 94,913 | 1,552,613 | - | - | Class A Common Stock | |
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 94,913 | 189,826 | - | - | Restricted Stock Units | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 94,913 | 151,093 | - | - | Class A Common Stock | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 94,913 | 189,826 | - | - | Restricted Stock Units | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 21 Nov 2025 | 89,375 | 216,322,088 (32%) | 0% | 1.3 | 118,422 | Common Stock |
| Babcock & Wilcox Enterprises Inc | Henry E. Bartoli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 85,000 | 0 | - | - | Restricted Stock Units | |
| Babcock & Wilcox Enterprises Inc | Henry E. Bartoli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.08 per share. | 21 Nov 2025 | 85,000 | 488,187 (1%) | 0% | 6.1 | 516,800 | Common Stock |
| Tapestry | Joanne C. Crevoiserat | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 81,000 | 143,081 | - | - | Stock Option | |
| Tapestry | Joanne C. Crevoiserat | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.97 per share. | 21 Nov 2025 | 81,000 | 698,968 (0%) | 0% | 21.0 | 1,698,570 | Common Stock |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | 21 Nov 2025 | 80,250 | 0 | - | - | Operating Partnership Units | ||
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 80,250 | 80,250 | - | - | Operating Partnership Units | |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 80,250 | 532,871 | - | - | Performance Units | |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | 21 Nov 2025 | 80,250 | 640,656 (0%) | 0% | 0 | Common Stock, par value $0.01 | ||
| Roblox Corp (Class A) | Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 80,000 | 6,370,831 | - | 0 | Class A Common Stock | |
| Electronic Arts | Huber Jeff | Director | Sale of securities on an exchange or to another person at price $ 201.17 per share. | 21 Nov 2025 | 79,381 | 0 (0%) | 0% | 201.2 | 15,968,687 | Common Stock |
| Karman Holdings Inc | Anthony Koblinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.48 per share. | 21 Nov 2025 | 75,000 | 2,540,826 | - | 58.5 | 4,386,000 | Common Stock |
| PLBY Grp Inc | Tracey Edmonds | Director | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 21 Nov 2025 | 75,000 | 215,010 | - | 1.7 | 123,975 | Common Stock |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 21 Nov 2025 | 70,010 | 31,053,279 | - | 1.1 | 74,911 | Class A Common Stock |
| Priority Technology Holdings | Ranjana Ram | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 69,231 | 0 | - | - | Restricted Stock Unit | |
| Amprius Tech Inc | Kang Sun | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.08 per share. | 21 Nov 2025 | 68,655 | 1,403,651 | - | 10.1 | 692,132 | Common stock |
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 42.78 per share. | 21 Nov 2025 | 65,659 | 456,647 (0%) | 0% | 42.8 | 2,808,892 | Common stock |
| Huntington Bancshares | Helga S. Houston | Senior Exec. V. P. | Sale of securities on an exchange or to another person at price $ 15.38 per share. | 21 Nov 2025 | 64,587 | 534,640 (0%) | 0% | 15.4 | 993,348 | Common Stock |
| Priority Technology Holdings | Sean Kiewiet | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 61,539 | 0 | - | - | Restricted Stock Unit | |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 21 Nov 2025 | 60,000 | 4,430,441 | - | 4.8 | 289,722 | Class A Common Stock |
| Upwork Inc | Hayden Brown | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 21 Nov 2025 | 60,000 | 1,047,894 (0%) | 0% | 18.2 | 1,092,114 | Common Stock |
| LifeStance Health Grp Inc | Lisa K. Miller | See Remarks | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 21 Nov 2025 | 57,240 | 261,292 | - | 6.4 | 368,053 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 21 Nov 2025 | 56,992 | 3,314,848 | - | 1.0 | 55,852 | Common Stock |
| Accuray Inc | Beverly A. Huss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | Beverly A. Huss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 243,965 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Joseph E. Whitters | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 667,656 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Joseph E. Whitters | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | James M. Hindman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | James M. Hindman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 294,804 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Anne B. Le Grand | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | Anne B. Le Grand | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 259,499 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Byron C. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 175,936 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Byron C. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | Mika Nishimura | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 0 | - | - | Restricted Stock Units | |
| Accuray Inc | Mika Nishimura | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,603 | 212,659 (0%) | 0% | 0 | Common Stock | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,180 | 56,180 | - | - | Class A Common Stock | |
| fuboTV Inc | John Janedis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 56,180 | 0 | - | - | Restricted Stock Units | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 21 Nov 2025 | 56,080 | 6,327,893 | - | 0.7 | 38,000 | Common Stock, par value $.001 |
| DBV Tech (ADR) | Kevin Michael Trapp | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 55,000 | 55,000 (0%) | 0% | 0 | Ordinary Shares | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 55,000 | 0 | - | - | Stock Option (right to buy) | |
| Therealreal Inc | Rati Sahi Levesque | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 53,566 | 1,604,178 (1%) | 0% | 13.1 | 699,572 | Common Stock |
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 50,625 | 0 | - | - | Stock option (right to buy) | |
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 21 Nov 2025 | 50,625 | 522,306 (0%) | 0% | 17 | 860,625 | Common stock |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 50,041 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Rene Russo | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 50,041 | 50,041 | - | - | Stock Option (right to buy) | |
| NOV Inc | Christian S. Kendall | Director | Purchase of securities on an exchange or from another person at price $ 14.50 per share. | 21 Nov 2025 | 50,000 | 85,949 (0%) | 0% | 14.5 | 725,000 | Common Stock |
| NextTrip Inc | Jimmy Don Byrd | Director | 21 Nov 2025 | 50,000 | 150,000 (10%) | 3% | 0 | Common Stock | ||
| NextTrip Inc | Jimmy Don Byrd | Director | 21 Nov 2025 | 50,000 | 0 | - | - | Series Q Nonvoting Convertible Preferred Stock | ||
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 21 Nov 2025 | 50,000 | 1,018,898 (3%) | 0% | 6.3 | 315,725 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 21 Nov 2025 | 50,000 | 1,018,898 (3%) | 0% | 6.3 | 315,725 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 21 Nov 2025 | 50,000 | 798,135 | - | 15.1 | 756,500 | Common Stock |
| Mirum Pharma Inc | Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 21 Nov 2025 | 50,000 | 50,000 (0%) | 0% | 2.9 | 146,800 | Common Stock |
| Mirum Pharma Inc | Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 50,000 | 281,176 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 21 Nov 2025 | 50,000 | 0 (0%) | 0% | 70 | 3,500,000 | Common Stock |
| Cerence Inc | Nils Schanz | EVP Product & Technology | Grant, award, or other acquisition of securities at price $ 10.35 per share. | 21 Nov 2025 | 49,905 | 254,886 (0%) | 0% | 10.4 | 516,517 | Common Stock |
| Cerence Inc | Christian Mentz | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 10.35 per share. | 21 Nov 2025 | 49,905 | 161,780 (0%) | 0% | 10.4 | 516,517 | Common Stock |
| Tapestry | Joanne C. Crevoiserat | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.31 per share. | 21 Nov 2025 | 49,265 | 617,968 (0%) | 0% | 105.3 | 5,188,097 | Common Stock |
| Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 21 Nov 2025 | 48,945 | 740,537 (1%) | 0% | 30.4 | 1,485,755 | Common Stock |
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.34 per share. | 21 Nov 2025 | 48,659 | 471,681 (0%) | 0% | 17.3 | 843,747 | Common stock |
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 48,659 | 0 | - | - | Stock option (right to buy) | |
| Central Bancompany Inc | Robert Marion Robuck | Director | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 47,619 | 47,619 | - | 21 | 999,999 | Class A Common Stock |
| Central Bancompany Inc | Robert Ringen Hermann | Director | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 47,619 | 47,619 | - | 21 | 999,999 | Class A Common Stock |
| Ardelyx Inc | Michael G. Raab | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 21 Nov 2025 | 46,887 | 1,455,363 (2%) | 0% | 5.5 | 259,609 | Common Stock |
| SoFi Tech Inc | Arun Pinto | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 24.76 per share. | 21 Nov 2025 | 46,132 | 138,396 | - | 24.8 | 1,142,219 | Common Stock |
| Accuray Inc | Steven F. Mayer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 45,620 | 400,229 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Steven F. Mayer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 45,620 | 0 | - | - | Restricted Stock Units | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 45,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 44,210 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 44,210 | 44,210 | - | - | Stock Option (right to buy) | |
| Tapestry | Scott A. Roe | CFO and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.85 per share. | 21 Nov 2025 | 43,987 | 104,162 (0%) | 0% | 104.9 | 4,612,037 | Common Stock |
| Central Bancompany Inc | John Thomas Ross | Director, President, CEO | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 42,000 | 42,000 | - | 21 | 882,000 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 21 Nov 2025 | 41,287 | 3,371,840 | - | 0.8 | 34,268 | Common Stock |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.30 per share. | 21 Nov 2025 | 39,760 | 968,898 (3%) | 0% | 6.3 | 250,305 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.30 per share. | 21 Nov 2025 | 39,760 | 968,898 (3%) | 0% | 6.3 | 250,305 | Common Stock |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 21 Nov 2025 | 39,238 | 439,119 (0%) | 0% | 2.7 | 104,679 | Class A common stock |
| Central Bancompany Inc | Sam Bryan Cook | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 38,619 | 38,619 | - | 21 | 810,999 | Class A Common Stock |
| Digi Intl Inc | Ronald E. Konezny | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 38,484 | 600,593 (2%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 37,296 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 37,296 | 37,296 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. | 21 Nov 2025 | 35,868 | 35,868 | - | 0.4 | 13,989 | Common Stock |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 35,868 | 0 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 35,868 | 0 | - | 0 | Common Stock | |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.81 per share. | 21 Nov 2025 | 35,687 | 139,849 (0%) | 0% | 33.8 | 1,206,577 | Common Stock |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 35,687 | 71,372 | - | - | Stock Option | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| NextTrip Inc | Stephen C. Kircher | Director | 21 Nov 2025 | 34,223 | 47,501 (3%) | 2% | 0 | Common Stock | ||
| NextTrip Inc | Stephen C. Kircher | Director | 21 Nov 2025 | 34,223 | 0 | - | - | Series Q Nonvoting Convertible Preferred Stock | ||
| Par Pacific Holdings Inc | William Monteleone | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.87 per share. | 21 Nov 2025 | 33,625 | 423,022 (0%) | 0% | 43.9 | 1,475,129 | Common stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.82 per share. | 21 Nov 2025 | 33,561 | 4,386,252 | - | 4.8 | 161,747 | Class A Common Stock |
| Kaiser Aluminum Corp | Keith A. Harvey | Director, President & CEO | Sale or transfer of securities back to the company at price $ 90.34 per share. | 21 Nov 2025 | 33,000 | 103,231 (0%) | 0% | 90.3 | 2,981,220 | Common Stock, par value $0.01 per share |
| Johnson Controls | Lei Zhang Schlitz | VP & Pres, Global Products | Sale of securities on an exchange or to another person at price $ 113.20 per share. | 21 Nov 2025 | 32,031 | 66,780 (0%) | 0% | 113.2 | 3,625,909 | Ordinary Shares |
| DBV Tech (ADR) | Virginie Boucinha | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 32,000 | 70,000 (0%) | 0% | 0 | Ordinary Shares | |
| Tapestry | Joanne C. Crevoiserat | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.31 per share. | 21 Nov 2025 | 31,735 | 667,233 (0%) | 0% | 105.3 | 3,342,013 | Common Stock |
| NextTrip Inc | Andrew Jay Kaplan | Director | 21 Nov 2025 | 31,250 | 36,250 (2%) | 2% | 0 | Common stock | ||
| NextTrip Inc | Andrew Jay Kaplan | Director | 21 Nov 2025 | 31,250 | 0 | - | - | Series Q Nonvoting Convertible Preferred Stock | ||
| First Interstate BancSystem Inc | John M. Heyneman | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 21 Nov 2025 | 30,432 | 1,414,636 (3%) | 0% | 31.0 | 944,305 | Common Stock |
| Gulf Resources Inc | Xiaobin Liu | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 30,000 | 43,812 (0%) | 0% | - | Common Stock | |
| Gulf Resources Inc | Min Li | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 30,000 | 43,812 (0%) | 0% | - | Common Stock | |
| Gulf Resources Inc | Naihui Miao | Director, COO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 30,000 | 43,812 (0%) | 0% | - | Common Stock | |
| Kirby Corp | David W. Grzebinski | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.93 per share. | 21 Nov 2025 | 29,451 | 109,160 (0%) | 0% | 73.9 | 2,177,312 | Common Stock, par value $0.10 per share |
| Kirby Corp | David W. Grzebinski | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 29,451 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Kirby Corp | David W. Grzebinski | Director, CEO | Sale of securities on an exchange or to another person at price $ 107.41 per share. | 21 Nov 2025 | 29,451 | 79,709 (0%) | 0% | 107.4 | 3,163,332 | Common Stock, par value $0.10 per share |
| Datavault AI Inc | Brett A. Moyer | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 21 Nov 2025 | 28,594 | 1,089,071 (4%) | 0% | 2.4 | 69,758 | Common Stock |
| Ziff Davis Inc | Vivek Shah | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 27,904 | 324,399 (0%) | 0% | 0 | Common Stock $0.01 Par Value | |
| Ziff Davis Inc | Vivek Shah | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 27,904 | 0 | - | - | Restricted Stock Units | |
| Innventure Inc | James O. Donnally | Director | Purchase of securities on an exchange or from another person at price $ 3.37 per share. | 21 Nov 2025 | 27,886 | 27,886 | - | 3.4 | 93,976 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 21 Nov 2025 | 27,297 | 3,287,551 | - | 0.9 | 25,113 | Common Stock |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 27,094 | 27,094 | - | - | Stock Option | |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.41 per share. | 21 Nov 2025 | 27,094 | 166,943 (0%) | 0% | 35.4 | 959,399 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 27,075 | 0 | - | - | Stock Options (Right to buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.03 per share. | 21 Nov 2025 | 27,075 | 71,828 (0%) | 0% | 11.0 | 298,637 | Common Stock |
| Amprius Tech Inc | C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.08 per share. | 21 Nov 2025 | 25,024 | 821,951 | - | 10.1 | 252,274 | Common stock |
| Bridgewater Bancshares Inc | Jerry J. Baack | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.47 per share. | 21 Nov 2025 | 25,000 | 1,189,361 (4%) | 0% | 7.5 | 186,750 | Common Stock |
| Bridgewater Bancshares Inc | Jerry J. Baack | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 125,000 | - | - | Option to buy | |
| Merit Medical Systems Inc | Fred P. Lampropoulos | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 87.31 per share. | 21 Nov 2025 | 25,000 | 1,029,955 (1%) | 0% | 87.3 | 2,182,750 | Common Stock, No Par Value |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 2,203,502 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 1,025,000 | - | - | Restricted Stock Unit Award | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 257,100 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 27,551 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.65 per share. | 21 Nov 2025 | 25,000 | 848,135 | - | 3.7 | 91,250 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 21 Nov 2025 | 25,000 | 823,135 | - | 2.2 | 56,000 | Common Stock |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 24,680 | 24,680 | - | - | Restricted Stock Unit Award | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 24,680 | 2,228,182 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Mineralys Therapeutics Inc | Jon Congleton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 24,082 | 0 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Jon Congleton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 21 Nov 2025 | 24,082 | 655,387 | - | 0.5 | 13,004 | Common Stock |
| Exelixis Inc | Dana T. Aftab | EVP, Research and Development | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 24,000 | 640,778 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 23,786 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 23,786 | 23,786 | - | - | Stock Option (right to buy) | |
| KalVista Pharma Inc | Benjamin L. Palleiko | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 23,250 | 427,129 (2%) | 0% | - | Common Stock | |
| KalVista Pharma Inc | Benjamin L. Palleiko | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 23,250 | 302,250 | - | - | Restricted Stock Unit | |
| Zurn Elkay Water Soln Corp | Sudhanshu Chhabra | VP-Zurn Business Systems | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 22,753 | 71,577 (0%) | 0% | 0 | Common Stock | |
| Zurn Elkay Water Soln Corp | Sudhanshu Chhabra | VP-Zurn Business Systems | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 22,753 | 22,753 (0%) | 0% | 0 | Common Stock | |
| Accuray Inc | Beverly A. Huss | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 21 Nov 2025 | 22,642 | 221,323 (0%) | 0% | 1.0 | 23,774 | Common Stock |
| Accuray Inc | Byron C. Scott | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 21 Nov 2025 | 22,642 | 153,294 (0%) | 0% | 1.0 | 23,774 | Common Stock |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 22,499 | 1,192,309 (1%) | 0% | 13.1 | 293,837 | Common Stock |
| Mobix Labs Inc (Class A) | James Aralis | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 21 Nov 2025 | 22,470 | 106,523 | - | 0.4 | 9,143 | Class A Common Stock |
| EchoStar Corp (Class A) | John W. Swieringa | PRES, TECH & COO | Sale of securities on an exchange or to another person at price $ 67.34 per share. | 21 Nov 2025 | 22,000 | 283,509 (0%) | 0% | 67.3 | 1,481,480 | Class A Common Stock |
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Sale of securities on an exchange or to another person at price $ 215.21 per share. | 21 Nov 2025 | 21,871 | 100,646 (0%) | 0% | 215.2 | 4,706,913 | Common Stock |
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 21 Nov 2025 | 21,871 | 122,517 (0%) | 0% | 62.3 | 1,363,001 | Common Stock |
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 21,871 | 24,729 | - | - | Employee Stock Option (Right to Buy) | |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 21 Nov 2025 | 21,000 | 28,202 (0%) | 0% | 26.2 | 549,990 | Common stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.25 per share. | 21 Nov 2025 | 21,000 | 49,202 (0%) | 0% | 9.3 | 194,250 | Common stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 21,000 | 175,117 | - | - | Stock option (right to buy) | |
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 21 Nov 2025 | 20,953 | 258,712 | - | 11 | 230,483 | Class A Common Stock |
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel | Sale of securities on an exchange or to another person at price $ 10.50 per share. | 21 Nov 2025 | 20,952 | 279,665 | - | 10.5 | 219,996 | Class A Common Stock |
| Datavault AI Inc | Nathaniel Bradley | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 21 Nov 2025 | 20,493 | 4,715,477 (18%) | 0% | 2.4 | 49,995 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.44 per share. | 21 Nov 2025 | 20,301 | 65,054 (0%) | 0% | 18.4 | 374,350 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 20,301 | 0 | - | - | Stock Options (Right to buy) | |
| OppFi Inc (Class A) | Jocelyn Moore | Director | Sale of securities on an exchange or to another person at price $ 9.23 per share. | 21 Nov 2025 | 20,200 | 51,730 | - | 9.2 | 186,385 | Class A Common Stock |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 2.74 per share. | 21 Nov 2025 | 20,121 | 418,998 (0%) | 0% | 2.7 | 55,033 | Class A common stock |
| IES Holdings Inc | Jeffrey L. Gendell | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 371.19 per share. | 21 Nov 2025 | 20,077 | 10,789,794 (50%) | 0% | 371.2 | 7,452,382 | Common Stock, par value $0.01 per share |
| Flex Ltd | William D. Watkins | Director | Sale of securities on an exchange or to another person at price $ 54.52 per share. | 21 Nov 2025 | 20,000 | 98,073 (0%) | 0% | 54.5 | 1,090,450 | Ordinary Shares |
| Bath & Body Works Inc | Steven E. Voskuil | Director | Purchase of securities on an exchange or from another person at price $ 15.04 per share. | 21 Nov 2025 | 20,000 | 33,925 (0%) | 0% | 15.0 | 300,700 | Common Stock, $0.50 par value |
| NOV Inc | Christian S. Kendall | Director | Purchase of securities on an exchange or from another person at price $ 14.36 per share. | 21 Nov 2025 | 20,000 | 35,949 (0%) | 0% | 14.4 | 287,200 | Common Stock |
| NeOnc Tech Holdings Inc | Amir Heshmatpour | Director, President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 21 Nov 2025 | 20,000 | 2,982,000 | - | 6.0 | 119,600 | CommonStock |
| Bunge Ltd | Christos Dimopoulos | Executive VP, Global Markets | Sale of securities on an exchange or to another person at price $ 94.37 per share. | 21 Nov 2025 | 20,000 | 104,536 (0%) | 0% | 94.4 | 1,887,418 | Common Stock |
| Sacks Parente Golf Inc | Brett Hoge | Director | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 21 Nov 2025 | 20,000 | 270,373 | - | 1.2 | 24,140 | Common Stock |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christopher Frankenfield | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Acrivon Therapeutics Inc | Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.30 per share. | 21 Nov 2025 | 19,904 | 2,046,771 | - | 2.3 | 45,779 | Common Stock |
| Therealreal Inc | Rati Sahi Levesque | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 19,285 | 1,657,744 (1%) | 0% | 13.1 | 251,862 | Common Stock |
| Tapestry | Scott A. Roe | CFO and COO | Sale of securities on an exchange or to another person at price $ 104.85 per share. | 21 Nov 2025 | 18,794 | 148,149 (0%) | 0% | 104.9 | 1,970,551 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.91 per share. | 21 Nov 2025 | 18,705 | 53,123 (0%) | 0% | 44.9 | 840,042 | Common Stock |
| Consolidated Water Co. Ltd | Frederick W. Mctaggart | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 33.50 per share. | 21 Nov 2025 | 18,152 | 269,158 (1%) | 0% | 33.5 | 608,092 | Common Stock |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 21 Nov 2025 | 17,795 | 163,150 | - | 3.8 | 67,439 | Common Stock |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 17,795 | 98,184 | - | - | Stock Option (Right to Buy) | |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.55 per share. | 21 Nov 2025 | 17,795 | 145,355 | - | 18.5 | 330,094 | Common Stock |
| McDonald's | Ian Frederick Borden | EVP - CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 17,134 | 0 | - | - | Options (Right to Buy) | |
| McDonald's | Ian Frederick Borden | EVP - CFO | Sale of securities on an exchange or to another person at price $ 310.00 per share. | 21 Nov 2025 | 17,134 | 26,353 (0%) | 0% | 310 | 5,311,540 | Common Stock |
| McDonald's | Ian Frederick Borden | EVP - CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 116.73 per share. | 21 Nov 2025 | 17,134 | 43,487 (0%) | 0% | 116.7 | 2,000,052 | Common Stock |
| Electronic Arts | Huber Jeff | Director | Sale of securities on an exchange or to another person at price $ 200.72 per share. | 21 Nov 2025 | 16,788 | 1,980 (0%) | 0% | 200.7 | 3,369,679 | Common Stock |
| Digi Intl Inc | Terrence G. Schneider | VP, SUPPLY CHAIN | Sale of securities on an exchange or to another person at price $ 40.56 per share. | 21 Nov 2025 | 16,667 | 24,756 (0%) | 0% | 40.6 | 675,947 | Common Stock |
| Digi Intl Inc | Terrence G. Schneider | VP, SUPPLY CHAIN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.94 per share. | 21 Nov 2025 | 16,667 | 41,423 (0%) | 0% | 17.9 | 299,006 | Common Stock |
| Digi Intl Inc | Terrence G. Schneider | VP, SUPPLY CHAIN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 16,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 21 Nov 2025 | 15,913 | 403,085 (0%) | 0% | 2.7 | 43,116 | Class A common stock |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 70.65 per share. | 21 Nov 2025 | 15,798 | 193,855 (0%) | 0% | 70.7 | 1,116,201 | Common Shares |
| Sarcos Tech and Robotics Corp | Denis Garagic | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 5.11 per share. | 21 Nov 2025 | 15,611 | 569,248 | - | 5.1 | 79,817 | Common Stock |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 68.89 per share. | 21 Nov 2025 | 15,499 | 221,953 (0%) | 0% | 68.9 | 1,067,670 | Common Shares |
| Evolv Tech Holdings Inc (Class A) | Kevin M. Charlton | Director | Purchase of securities on an exchange or from another person at price $ 5.68 per share. | 21 Nov 2025 | 15,000 | 44,081 | - | 5.7 | 85,196 | Class A Common Stock |
| Therealreal Inc | Rati Sahi Levesque | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 15,000 | 1,677,029 (1%) | 0% | 13.1 | 195,900 | Common Stock |
| Celcuity Inc | David F. Dalvey | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 21 Nov 2025 | 15,000 | 110,000 (1%) | 0% | 100.0 | 1,500,017 | Common Stock |
| Supernus Pharma Inc | Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Charles W. Newhall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 21 Nov 2025 | 15,000 | 119,644 (0%) | 0% | 13.0 | 194,700 | Common Stock |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Katarina Luptakova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharma Inc | Brian Piekos | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 65,000 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Brian Piekos | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 15,000 | 15,000 (0%) | 0% | - | Common Stock | |
| Open Lending Corp | Abhijit Chaudhary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 14,943 | 14,943 | - | - | Restricted Stock Units | |
| Digi Intl Inc | James J. Loch | SR VP, CFO AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 14,610 | 139,256 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.92 per share. | 21 Nov 2025 | 14,586 | 50,468 (0%) | 0% | 44.9 | 655,189 | Common Stock |
| Tenable Holdings Inc | Matthew C. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 14,544 | 218,168 | - | - | Restricted Stock Units | |
| Tenable Holdings Inc | Matthew C. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 14,544 | 14,544 (0%) | 0% | 0 | Common Stock | |
| Zai Lab Ltd (ADR) | Frazor Titus Edmondson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 19.78 per share. | 21 Nov 2025 | 14,328 | 27,737 (0%) | 0% | 19.8 | 283,408 | American Depositary Shares |
| Ziff Davis Inc | Vivek Shah | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.35 per share. | 21 Nov 2025 | 14,244 | 310,155 (0%) | 0% | 30.3 | 432,305 | Common Stock $0.01 Par Value |
| IES Holdings Inc | Matthew J. Simmes | President and CEO | Grant, award, or other acquisition of securities at price $ 371.19 per share. | 21 Nov 2025 | 14,172 | 115,676 (0%) | 0% | 371.2 | 5,260,505 | Common Stock |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 63.81 per share. | 21 Nov 2025 | 14,000 | 1,164,458 (1%) | 0% | 63.8 | 893,404 | Air Lease Corporation - Class A Common Stock |
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 21 Nov 2025 | 13,969 | 300,617 | - | 10 | 139,690 | Class A Common Stock |
| NextTrip Inc | Carmen L. Diges | Director | 21 Nov 2025 | 13,580 | 13,580 (0%) | 0% | 0 | Common Stock | ||
| NextTrip Inc | Carmen L. Diges | Director | 21 Nov 2025 | 13,580 | 0 | - | - | Series Q Nonvoting Convertible Preferred Stock | ||
| Amazon | David A. Zapolsky | Senior Vice President | Sale of securities on an exchange or to another person at price $ 222.49 per share. | 21 Nov 2025 | 13,570 | 41,190 (0%) | 0% | 222.5 | 3,019,189 | Common Stock, par value $.01 per share |
| RLJ Lodging Trust | Robin McBride Zeigler | Director | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 21 Nov 2025 | 13,413 | 37,159 (0%) | 0% | 7.5 | 100,732 | Common Stock |
| IES Holdings Inc | Jeffrey L. Gendell | Director, Executive Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 371.19 per share. | 21 Nov 2025 | 13,179 | 10,776,615 (50%) | 0% | 371.2 | 4,891,913 | Common Stock, par value $0.01 per share |
| Hallador Energy Co | Charles Wesley | Director | Purchase of securities on an exchange or from another person at price $ 19.28 per share. | 21 Nov 2025 | 13,000 | 247,914 (0%) | 0% | 19.3 | 250,665 | Common Stock |
| Traws Pharma Inc | John H. Leaman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 12,770 | 12,770 | - | - | Stock Option (right to purchase) | |
| Magnite Inc | Robert F. Spillane | Director | Sale of securities on an exchange or to another person at price $ 14.22 per share. | 21 Nov 2025 | 12,500 | 53,917 (0%) | 0% | 14.2 | 177,750 | Common Stock |
| Upwork Inc | Gary Steele | Director | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 21 Nov 2025 | 12,500 | 85,129 (0%) | 0% | 17.5 | 218,849 | Common Stock |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 69.84 per share. | 21 Nov 2025 | 12,300 | 209,653 (0%) | 0% | 69.8 | 859,048 | Common Shares |
| Nektar Therapeutics | Howard W. Robin | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 12,170 | 12,170 | - | - | Stock Option | |
| Therealreal Inc | Todd A. Suko | Chief Legal Officer and Secret | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 12,000 | 684,062 (0%) | 0% | 13.1 | 156,720 | Common Stock |
| AXT Inc | Morris S. Young | CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 12,000 | 2,464,360 (6%) | 0% | 0 | Common Stock | |
| Roadzen Inc | Rohan Malhotra | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 21 Nov 2025 | 12,000 | 819,837 | - | 1.4 | 17,160 | Ordinary Shares |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 21 Nov 2025 | 12,000 | 756,460 | - | 0.8 | 9,600 | Common Stock |
| DiaMedica Therapeutics Inc | James Parsons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 21 Nov 2025 | 12,000 | 87,854 (0%) | 0% | 2.2 | 26,400 | Common Stock |
| Merchants Bancorp | Michael F. Petrie | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.20 per share. | 21 Nov 2025 | 11,566 | 86,164 | - | 19.2 | 222,067 | Series C Depositary Shares |
| Priority Technology Holdings | Rajiv Kumar | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 11,539 | 0 | - | - | Restricted Stock Unit | |
| Devon Energy | Dennis C. Cameron | EVP and General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 11,411 | 246,160 (0%) | 0% | 0 | Common Stock | |
| i3 Verticals Inc (Class A) | Frederick Stanford | President | Sale of securities on an exchange or to another person at price $ 24.21 per share. | 21 Nov 2025 | 11,347 | 43,653 (0%) | 0% | 24.2 | 274,711 | Class A common stock, par value $0.0001 per share |
| Outfront Media Inc | Manuel A. Diaz Rodriguez | Director | Sale of securities on an exchange or to another person at price $ 22.18 per share. | 21 Nov 2025 | 11,270 | 58,786 (0%) | 0% | 22.2 | 249,969 | Common Stock |
| Central Bancompany Inc | Richard Hays McClure | Director | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 11,200 | 11,200 | - | 21 | 235,200 | Class A Common Stock |
| Joby Aviation Inc | Greg Bowles | Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 11,156 | 55,780 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Greg Bowles | Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 11,156 | 167,620 | - | 0 | Common Stock | |
| UNIFI Inc | Hongjun Ning | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 11,128 | 11,128 (0%) | 0% | - | Common Stock | |
| UNIFI Inc | Hongjun Ning | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 11,128 | 0 | - | - | Restricted Stock Units | |
| UNIFI Inc | Hongjun Ning | EVP | Sale or transfer of securities back to the company at price $ 3.13 per share. | 21 Nov 2025 | 11,128 | 0 (0%) | 0% | 3.1 | 34,831 | Common Stock |
| Ardelyx Inc | Joseph Reilly | See Remarks | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 21 Nov 2025 | 11,086 | 108,914 (0%) | 0% | 5.5 | 61,382 | Common Stock |
| KalVista Pharma Inc | Benjamin L. Palleiko | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 21 Nov 2025 | 10,940 | 416,189 (2%) | 0% | 13.5 | 147,154 | Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.77 per share. | 21 Nov 2025 | 10,628 | 4,419,813 | - | 4.8 | 50,675 | Class A Common Stock |
| Block Inc (Class A) | Owen Britton Jennings | Business Lead | Sale of securities on an exchange or to another person at price $ 61.40 per share. | 21 Nov 2025 | 10,417 | 243,540 (0%) | 0% | 61.4 | 639,604 | Class A Common Stock |
| Kirby Corp | Amy D. Husted | Exec VP General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,413 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Kirby Corp | Amy D. Husted | Exec VP General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 107.42 per share. | 21 Nov 2025 | 10,413 | 11,760 (0%) | 0% | 107.4 | 1,118,564 | Common Stock, par value $0.10 per share |
| Kirby Corp | Amy D. Husted | Exec VP General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.93 per share. | 21 Nov 2025 | 10,413 | 22,173 (0%) | 0% | 73.9 | 769,833 | Common Stock, par value $0.10 per share |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 63.85 per share. | 21 Nov 2025 | 10,300 | 1,154,158 (1%) | 0% | 63.9 | 657,687 | Air Lease Corporation - Class A Common Stock |
| Yum Brands | Christopher L. Turner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 10,136 | 10,136 | - | - | Stock Appreciation Right | |
| Yum Brands | Christopher L. Turner | Director, CEO, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 10,136 | 10,136 | - | - | Stock Appreciation Right | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 21 Nov 2025 | 10,000 | 2,480,539 (38%) | 0% | 3.5 | 34,900 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 21 Nov 2025 | 10,000 | 2,490,539 (38%) | 0% | 3.5 | 35,000 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 20.90 per share. | 21 Nov 2025 | 10,000 | 237,299 (0%) | 0% | 20.9 | 209,000 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 21 Nov 2025 | 10,000 | 217,299 (0%) | 0% | 21.5 | 215,000 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 20.80 per share. | 21 Nov 2025 | 10,000 | 227,299 (0%) | 0% | 20.8 | 208,000 | Common Stock |
| Bristow Grp Inc | G. Mark Mickelson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 50,265 | - | 0 | Common Stock | |
| Valvoline Inc | J. Kevin Willis | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 31.41 per share. | 21 Nov 2025 | 10,000 | 22,725 (0%) | 0% | 31.4 | 314,100 | Common Stock |
| PC Connection Inc | Timothy J. McGrath | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 271,586 (1%) | 0% | 0 | Common Stock | |
| PC Connection Inc | Timothy J. McGrath | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Doximity Inc (Class A) | Timothy S. Cabral | Director | 21 Nov 2025 | 10,000 | 13,221 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Timothy S. Cabral | Director | 21 Nov 2025 | 10,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Timothy S. Cabral | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 10,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Timothy S. Cabral | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 333,500 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Timothy S. Cabral | Director | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 21 Nov 2025 | 10,000 | 3,221 | - | 50 | 500,000 | Class A Common Stock |
| Fossil Grp Inc | Pamela J. Edwards | Director | Purchase of securities on an exchange or from another person at price $ 2.37 per share. | 21 Nov 2025 | 10,000 | 12,466 (0%) | 0% | 2.4 | 23,700 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 21 Nov 2025 | 10,000 | 217,299 (0%) | 0% | 21.5 | 215,000 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 20.80 per share. | 21 Nov 2025 | 10,000 | 227,299 (0%) | 0% | 20.8 | 208,000 | Common Stock |
| Knowles Corp | John S. Anderson | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 20.90 per share. | 21 Nov 2025 | 10,000 | 237,299 (0%) | 0% | 20.9 | 209,000 | Common Stock |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 21 Nov 2025 | 10,000 | 744,460 | - | 0.8 | 8,000 | Common Stock |
| Industrial Logistics Properties Trust | Kevin C. Phelan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 5,500 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emma Reeve | Director | Sale of securities on an exchange or to another person at price $ 79.50 per share. | 21 Nov 2025 | 10,000 | 6,666 (0%) | 0% | 79.5 | 795,000 | Common Stock |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.16 per share. | 21 Nov 2025 | 10,000 | 16,666 (0%) | 0% | 51.2 | 511,600 | Common Stock |
| West Bancorp | George D. Milligan | Director | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 21 Nov 2025 | 10,000 | 53,195 (0%) | 0% | 21.7 | 217,100 | COMMON STOCK |
| Block Inc (Class A) | Amrita Ahuja | CFO & COO | Sale of securities on an exchange or to another person at price $ 61.40 per share. | 21 Nov 2025 | 9,959 | 272,965 (0%) | 0% | 61.4 | 611,483 | Class A Common Stock |
| Huntington Bancshares | Helga S. Houston | Senior Exec. V. P. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.06 per share. | 21 Nov 2025 | 9,940 | 605,734 (0%) | 0% | 10.1 | 99,996 | Common Stock |
| Huntington Bancshares | Helga S. Houston | Senior Exec. V. P. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 9,940 | 0 | - | - | Employee/Director Stock Option (Right to Buy) | |
| Valero Energy | Jason W. Fraser | EVP & CFO | Sale of securities on an exchange or to another person at price $ 174.02 per share. | 21 Nov 2025 | 9,933 | 134,196 (0%) | 0% | 174.0 | 1,728,540 | Common Stock |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 9,760 | 9,760 | - | - | Restricted Stock Unit Award | |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 9,760 | 507,942 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Cisco | M. Victoria Wong | SVP & Chief Acctg Officer | Sale of securities on an exchange or to another person at price $ 76.37 per share. | 21 Nov 2025 | 9,701 | 33,125 (0%) | 0% | 76.4 | 740,900 | Common Stock |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 216.74 per share. | 21 Nov 2025 | 9,688 | 2,214,528 (0%) | 0% | 216.7 | 2,099,796 | Common Stock, par value $.01 per share |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.28 per share. | 21 Nov 2025 | 9,559 | 1,502,479 | - | 11.3 | 107,861 | Class A Common Stock |
| Enovix Corp | Rajendra K. Talluri | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2025 | 9,427 | 2,303,812 | - | 0 | Common Stock | |
| Chevron | Jeff B. Gustavson | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 9,325 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Jeff B. Gustavson | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.29 per share. | 21 Nov 2025 | 9,325 | 1,675 (0%) | 0% | 83.3 | 776,679 | Common Stock |
| Chevron | Jeff B. Gustavson | Vice President | Sale of securities on an exchange or to another person at price $ 150.27 per share. | 21 Nov 2025 | 9,325 | 1,675 (0%) | 0% | 150.3 | 1,401,283 | Common Stock |
| Therealreal Inc | Todd A. Suko | Chief Legal Officer and Secret | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 9,000 | 696,062 (0%) | 0% | 13.1 | 117,540 | Common Stock |
| Central Bancompany Inc | Sam Bryan Cook | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 21 Nov 2025 | 9,000 | 9,000 | - | 21 | 189,000 | Class A Common Stock |
| Codexis Inc | Dennis P. Wolf | Director | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 21 Nov 2025 | 8,952 | 138,951 (0%) | 0% | 1.6 | 13,988 | Common Stock |
| Entrada Therapeutics Inc | Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.98 per share. | 21 Nov 2025 | 8,910 | 110,026 | - | 10.0 | 88,932 | Common Stock |
| IES Holdings Inc | Tracy A. McLauchlin | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 371.19 per share. | 21 Nov 2025 | 8,857 | 75,034 (0%) | 0% | 371.2 | 3,287,630 | Common Stock |
| Amazon | David A. Zapolsky | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 8,760 | 8,780 | - | - | Restricted Stock Unit Award | |
| Amazon | David A. Zapolsky | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 8,760 | 52,870 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Brian T. Olsavsky | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 8,760 | 57,760 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Brian T. Olsavsky | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 8,760 | 8,780 | - | - | Restricted Stock Unit Award | |
| Digi Intl Inc | David H. Sampsell | VP, CORP. DEV, GC & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 21 Nov 2025 | 8,748 | 31,757,255 (109%) | 0% | 41.5 | 363,245 | Common Stock |
| Digi Intl Inc | David H. Sampsell | VP, CORP. DEV, GC & CORP. SEC. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 8,748 | 324 | - | - | Employee Stock Option (right to buy) | |
| Digi Intl Inc | David H. Sampsell | VP, CORP. DEV, GC & CORP. SEC. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.53 per share. | 21 Nov 2025 | 8,748 | 31,766,003 (109%) | 0% | 21.5 | 188,344 | Common Stock |
| Therealreal Inc | Steve Lo | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 8,571 | 311,410 (0%) | 0% | 13.1 | 111,937 | Common Stock |
| Verastem Inc | Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 21 Nov 2025 | 8,550 | 8,666 (0%) | 0% | 10 | 85,500 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 21 Nov 2025 | 8,370 | 44,753 (0%) | 0% | 45.3 | 379,538 | Common Stock |
| Amazon | Matthew S. Garman | CEO Amazon Web Services | Sale of securities on an exchange or to another person at price $ 216.68 per share. | 21 Nov 2025 | 8,327 | 11,822 (0%) | 0% | 216.7 | 1,804,319 | Common Stock, par value $.01 per share |
| Datavault AI Inc | Stanley Mbugua | See Remarks | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 21 Nov 2025 | 8,219 | 316,199 (1%) | 0% | 2.4 | 20,051 | Common Stock |
| Therealreal Inc | Luke T. Friang | Chief Product & Tech Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 21 Nov 2025 | 8,137 | 501,652 (0%) | 0% | 13.1 | 106,269 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.